Mark Johnson
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Plant biochemistry and biosynthesis 5
- Biochemical and Molecular Research 4
- Muscle Physiology and Disorders 3
- Natural product bioactivities and synthesis 3
-
- HIV/AIDS drug development and treatment 10
- Co-authors
- Arnold Fridland (6 shared papers)Rodney Croteau (4 shared papers)David R. Appleton (1 shared paper)Andrew Weightman (1 shared paper)J. P. Polgár (1 shared paper)Katy H. P. Moore (2 shared papers)Dana M. Johnson (5 shared papers)Rodney Croteau (2 shared papers)
- Journals
- Biochemical Pharmacology (3 papers)Academic Emergency Medicine (2 papers)Macromolecules (2 papers)Archives of Biochemistry and Biophysics (2 papers)American Journal of Roentgenology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Johnson
66 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 167
- Virology 430
- Infectious Diseases 683
- Clinical Biochemistry 177
- Hepatology 181
- Emergency Medicine 149
Countries citing papers authored by Mark Johnson
This map shows the geographic impact of Mark Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Johnson more than expected).
Fields of papers citing papers by Mark Johnson
This network shows the impact of papers produced by Mark Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Johnson. The network helps show where Mark Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 286 | |
| 2 | 1973 | 276 | |
| 3 | 1999 | 235 | |
| 4 | 2011 | 214 | |
| 5 | 1989 | 162 | |
| 6 | 1998 | 157 | |
| 7 | 2009 | 141 | |
| 8 | 1993 | 137 | |
| 9 | 1988 | 118 | |
| 10 | 1995 | 107 | |
| 11 | 2012 | 107 | |
| 12 | 1987 | 94 | |
| 13 | 1994 | 87 | |
| 14 | 1987 | 82 | |
| 15 | 1998 | 82 | |
| 16 | 1977 | 72 | |
| 17 | 1995 | 69 | |
| 18 | 2007 | 67 | |
| 19 | 1984 | 66 | |
| 20 | 1995 | 60 |
About Mark Johnson
Mark Johnson is a scholar working on Molecular Biology, Infectious Diseases, Virology, Biomedical Engineering and Epidemiology, having authored 69 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (8 papers), Plant biochemistry and biosynthesis (5 papers), Biochemical and Molecular Research (4 papers), Advanced Polymer Synthesis and Characterization (3 papers), Muscle Physiology and Disorders (3 papers), Natural product bioactivities and synthesis (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Virology (430 citations), Infectious Diseases (683 citations), Clinical Biochemistry (177 citations), Hepatology (181 citations) and Emergency Medicine (149 citations). Mark Johnson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Arnold Fridland, Rodney Croteau, David R. Appleton, Andrew Weightman, J. P. Polgár, Katy H. P. Moore, Dana M. Johnson, Rodney Croteau, Geoffrey J. Yuen and Alan Bye. Their work appears in journals such as Biochemical Pharmacology, Academic Emergency Medicine, Macromolecules, Archives of Biochemistry and Biophysics and American Journal of Roentgenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.